The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
about
Clinical implications and utility of field cancerizationMGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer casesEpigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis.Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysisAbsence of MGMT promoter methylation in endometrial cancerDNA methylation in endometrial cancerEpigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma.Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum.Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer.Microsatellite instability use in mismatch repair gene sequence variant classificationSynchronous primary ovarian and endometrial cancers: a series of cases and a review of literatureEndothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signalingHereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFκB activation in the tumor stroma.Modal variety of microsatellite instability in human endometrial carcinomas.Future directions in the management of epithelial ovarian cancer.Application of DNA methylation biomarkers for endometrial cancer management.Pharmaco(epi)genomics in ovarian cancer.Role of epigenomics in ovarian and endometrial cancers.Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review.Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases.Synchronous endometrioid endometrial and ovarian cancer in a 34-year-old woman.Association between MGMT Promoter Methylation and Risk of Breast and Gynecologic Cancers: A Systematic Review and Meta-Analysis.Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis.Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.Inactivation of O⁶-methyguanine-DNA methyltransferase by promoter hypermethylation: association of epithelial ovarian carcinogenesis in specific histological types.High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.
P2860
Q33278836-3D83AD0A-BAB4-4681-B692-41C116CDD67BQ33750187-9C9D2E33-C665-4A58-843C-BC812BAE0744Q33894043-1ECF1350-F144-4A57-8147-7A270C469CF3Q34044661-C1F64CAD-C653-4882-B5AE-D18C34C82C4EQ34171450-18F8AFFC-C98D-4E97-9085-5ED86DEA200AQ34195371-D49EAD2D-FA08-48DB-A06B-333D6AA811E2Q34423868-90AA247B-7FDC-4918-8003-A61037476F8CQ34504432-0CE4BB73-90F5-4876-BE80-2A8BA59A7763Q35029716-9FBC0574-9CC0-4A9F-8E03-67D0D17719DCQ35808472-47EE6681-56FA-47D1-A486-BAF637DB7BE2Q35903507-F587B8EB-5535-4B93-91AB-17683D49A18AQ36462813-4A2669FD-C635-4652-8170-A8799FF54E84Q36472233-2543AE77-63E9-497C-95A2-0E34491CB1F0Q36474899-65BA08DB-3659-4976-B7A2-3066288C9FBBQ37179400-1336DE80-374C-4512-99BF-6A74D9955064Q37266484-D33D4A79-8F96-434F-8574-A9D5FAC2A9B2Q37346198-E4AAB3B3-2A9E-4746-AD67-F8ABEEB33BA5Q37961734-C867308F-620A-4E2F-ACEA-8790B576E4BDQ38123671-2D7F4E69-D13C-4933-AB9A-D89101D8ECFAQ38321607-B2BE84B9-0491-4992-A79D-2D9C2D50A4E6Q39282288-48D9A6C5-4E34-43C3-9BAE-2E63E0588936Q39354975-50DBA593-F50A-4DED-924E-E40E024A5FCEQ42264507-6D126A7F-9802-4477-B498-A4512B08F1A4Q42371780-99537827-F8A6-46F7-8071-D150092268D3Q47806873-A425C7C2-6CE3-46D1-B018-1C362E869B26Q49937490-D26CDF65-6D41-4083-89CA-1383BB5679CEQ50720259-E72E0151-FAFF-4E93-9980-3B7FFFD6E7C5Q51044072-E0AEE9E8-7A05-4018-AA5C-2295855A275FQ53249908-2049DC7C-7990-466F-BBF2-291569013292
P2860
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The high frequency of de novo ...... etrial and ovarian carcinomas.
@ast
The high frequency of de novo ...... etrial and ovarian carcinomas.
@en
type
label
The high frequency of de novo ...... etrial and ovarian carcinomas.
@ast
The high frequency of de novo ...... etrial and ovarian carcinomas.
@en
prefLabel
The high frequency of de novo ...... etrial and ovarian carcinomas.
@ast
The high frequency of de novo ...... etrial and ovarian carcinomas.
@en
P2093
P1476
The high frequency of de novo ...... metrial and ovarian carcinomas
@en
P2093
Barbara Marcomini
Carlo Capella
Emanuele Dainese
Ileana Carnevali
Roberta Cerutti
P304
P356
10.1158/1078-0432.CCR-05-2679
P407
P433
P577
2006-06-01T00:00:00Z